BCB RIVNCT04104529
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
At risk: Primary completion moved at least 2 years 11 months later.
See at-risk trials from Institut du Cancer de Montpellier - Val d'Aurelle
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 15 versions: 11 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Study completion pushed from Oct 2029 to Oct 2036
Notable Primary and study completion pushed from Oct 2026 to Oct 2029 Show 4 more changesShow less
- Eligibility criteria expanded, about 21 words
- Study description expanded, about 38 words
- Site details revised at 1 of 4 sites
- Publications: 25 to 29
- Minor Publications: 24 to 25v12
- Minor Site details revised at 1 of 4 sitesv9
- Minor Study sites: 3 to 4v8
Show 5 earlier versionsHide 5 earlier versions
- Minor Site details revised at 1 of 3 sitesv7
- Minor Publications: 2 to 24v6
Notable Primary and study completion dates: Oct 2024 to Oct 2026v5 Show 4 more changesShow less
- Eligibility criteria shortened, about 3 words
- Study sites: 1 to 3
- Interventions: Biological collection (Other) to Biological collection (Other), tumor collection (Other)
- Study description expanded, about 124 words
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Oct 2019 to Oct 28, 2019
- Minor Study description shortened, about 5 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Biological collection For all the patients include in the study : samples of blood samples collected before and during treatment. In parallel to this biological collection, standardized clinical data will be entered into a database Ancillary study : For metastatic thyroïd cancer and neuroendocrine tumor : anapath blocks of the initial diagnosis will be archived and dosimetric data will be collected for the cycle 1 For neuroendocrine tumor : blood sample additionnal will be realized at the cycle 1 (pre and post treatment)
Other: Biological collection, tumor collection
Sites
4 sites in 1 country